Life Sciences – Just Another Way to Say “Intellectual Property”?
There is no corner of the American economy more deeply dependent on intellectual property rights than the life sciences. Of course, we all know that patents have long been central to the success of...
View ArticleThe Federal Circuit’s Recent “Safe Harbor” Ruling Could Impact Biosimilars...
A recent Federal Circuit case, Momenta v. Amphastar, involves the Hatch-Waxman 271(e)(1) safe harbor, and is rousing the biologics and biosimilars industry. In particular, the court held in Momenta,...
View ArticlePatent War Between St. Jude Medical and Volcano Has Mixed Results
St. Jude Medical and Volcano have been embroiled in a legal battle over patents held by both companies, related to pressure wire technology that is used for heart patients. The battle began over two...
View Article2013 Should Bring Clarity to Analysis of Settlements of Pharmaceutical Patent...
The Federal Trade Commission (FTC) recently filed a brief with the U.S. Supreme Court in a case that promises to bring some clarity to the analysis of settlements of pharmaceutical patent litigation....
View ArticleFive Tips for Dealing with “First Inventor to File”
It’s here. Thanks to the America Invents Act (AIA), as of March 16, 2013, the U.S. patent system became a “first inventor to file” system. That is, the inventor who files first will get a patent, even...
View ArticleThe Perils and Promise of 3D Printing: Are DIY Life Sciences in Your Future?
With news that 3D printing (without question one of the coolest technologies to come down the road in quite some time) can be used to produce guns, we must now ask ourselves what other things might be...
View ArticleWhat Goes Up…Must Come Down: Viagra patent invalidated by Canadian Supreme Court
Pfizer and Teva have been fighting a legal battle over Pfizer’s patent for Viagra in Canada. The first shot was fired when Novopharm Limited, now Teva Pharmaceutical Industries, applied for a notice of...
View ArticleNavigating the Isolated DNA Patent Eligibility Jungle
For over 150 years the Supreme Court has provided three categories of exceptions to patent eligibility under 35 U.S.C §101: abstract ideas, laws of nature, and physical phenomena, since these are the...
View ArticleUnited Nations Firming Up Model Law on ‘Falsified’ Drugs
The United Nations Office on Drugs & Crime (UNODC) is meeting in Vienna this week to firm up a model law carrying harsh penalties for ‘falsified’ drug-related crimes, reviving fears about seizures...
View Article
